in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance.
.
copyright © 2018 bennett, coleman & co. ltd. all rights reserved.
.
shuki sadeh
.
. taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said.
.
© 2018 southern california public radio